GN Store Nord A/S (GN.CO)
DKK 135.6
(7.45%)
DKK 135.6
(7.45%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 18.12 Billion DKK | -3.03% |
| 2022 | 18.68 Billion DKK | 18.46% |
| 2021 | 15.77 Billion DKK | 17.29% |
| 2020 | 13.44 Billion DKK | 6.96% |
| 2019 | 12.57 Billion DKK | 18.54% |
| 2018 | 10.6 Billion DKK | 10.66% |
| 2017 | 9.58 Billion DKK | 10.8% |
| 2016 | 8.65 Billion DKK | 2.94% |
| 2015 | 8.4 Billion DKK | 14.5% |
| 2014 | 7.34 Billion DKK | 8.08% |
| 2013 | 6.79 Billion DKK | 8.64% |
| 2012 | 6.25 Billion DKK | 12.35% |
| 2011 | 5.56 Billion DKK | 8.14% |
| 2010 | 5.14 Billion DKK | 8.8% |
| 2009 | 4.72 Billion DKK | -15.91% |
| 2008 | 5.62 Billion DKK | -5.97% |
| 2007 | 5.98 Billion DKK | 75.24% |
| 2006 | 3.41 Billion DKK | -48.63% |
| 2005 | 6.64 Billion DKK | 19.75% |
| 2004 | 5.54 Billion DKK | 17.0% |
| 2003 | 4.74 Billion DKK | -13.97% |
| 2002 | 5.51 Billion DKK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 4.49 Billion DKK | 4.55% |
| 2024 Q1 | 4.3 Billion DKK | -15.11% |
| 2023 Q2 | 4.39 Billion DKK | 4.27% |
| 2023 Q4 | 5.06 Billion DKK | 14.09% |
| 2023 Q3 | 4.44 Billion DKK | 1.12% |
| 2023 FY | 18.12 Billion DKK | -3.03% |
| 2023 Q1 | 4.21 Billion DKK | -20.04% |
| 2022 Q4 | 5.27 Billion DKK | 12.1% |
| 2022 Q2 | 4.85 Billion DKK | 25.86% |
| 2022 FY | 18.68 Billion DKK | 18.46% |
| 2022 Q3 | 4.7 Billion DKK | -3.21% |
| 2022 Q1 | 3.85 Billion DKK | -5.88% |
| 2021 FY | 15.77 Billion DKK | 17.29% |
| 2021 Q1 | 4.11 Billion DKK | 0.64% |
| 2021 Q3 | 3.78 Billion DKK | 0.24% |
| 2021 Q4 | 4.1 Billion DKK | 8.27% |
| 2021 Q2 | 3.77 Billion DKK | -8.08% |
| 2020 Q1 | 2.96 Billion DKK | -19.46% |
| 2020 Q3 | 3.73 Billion DKK | 40.62% |
| 2020 Q4 | 4.08 Billion DKK | 9.23% |
| 2020 Q2 | 2.65 Billion DKK | -10.38% |
| 2020 FY | 13.44 Billion DKK | 6.96% |
| 2019 Q4 | 3.68 Billion DKK | 22.84% |
| 2019 Q3 | 2.99 Billion DKK | -1.7% |
| 2019 FY | 12.57 Billion DKK | 18.54% |
| 2019 Q2 | 3.05 Billion DKK | 7.43% |
| 2019 Q1 | 2.84 Billion DKK | -10.89% |
| 2018 Q2 | 2.56 Billion DKK | 11.67% |
| 2018 Q4 | 3.18 Billion DKK | 24.49% |
| 2018 FY | 10.6 Billion DKK | 10.66% |
| 2018 Q1 | 2.29 Billion DKK | -14.23% |
| 2018 Q3 | 2.56 Billion DKK | -0.16% |
| 2017 FY | 9.58 Billion DKK | 10.8% |
| 2017 Q2 | 2.39 Billion DKK | 7.17% |
| 2017 Q4 | 2.67 Billion DKK | 17.31% |
| 2017 Q3 | 2.28 Billion DKK | -4.64% |
| 2017 Q1 | 2.23 Billion DKK | -10.93% |
| 2016 Q4 | 2.5 Billion DKK | 18.42% |
| 2016 FY | 8.65 Billion DKK | 2.94% |
| 2016 Q3 | 2.11 Billion DKK | -5.99% |
| 2016 Q1 | 2.09 Billion DKK | -14.85% |
| 2016 Q2 | 2.25 Billion DKK | 7.6% |
| 2015 FY | 8.4 Billion DKK | 14.5% |
| 2015 Q4 | 2.45 Billion DKK | 21.32% |
| 2015 Q3 | 2.02 Billion DKK | -0.44% |
| 2015 Q2 | 2.03 Billion DKK | 7.96% |
| 2015 Q1 | 1.88 Billion DKK | -11.08% |
| 2014 Q1 | 1.67 Billion DKK | -9.73% |
| 2014 FY | 7.34 Billion DKK | 8.08% |
| 2014 Q2 | 1.8 Billion DKK | 7.56% |
| 2014 Q3 | 1.73 Billion DKK | -3.93% |
| 2014 Q4 | 2.12 Billion DKK | 22.19% |
| 2013 Q1 | 1.62 Billion DKK | -7.77% |
| 2013 FY | 6.79 Billion DKK | 8.64% |
| 2013 Q4 | 1.86 Billion DKK | 15.6% |
| 2013 Q3 | 1.6 Billion DKK | -5.07% |
| 2013 Q2 | 1.69 Billion DKK | 4.18% |
| 2012 Q3 | 1.49 Billion DKK | -1.39% |
| 2012 Q4 | 1.76 Billion DKK | 18.07% |
| 2012 FY | 6.25 Billion DKK | 12.35% |
| 2012 Q1 | 1.47 Billion DKK | -6.04% |
| 2012 Q2 | 1.51 Billion DKK | 2.5% |
| 2011 Q3 | 1.35 Billion DKK | 1.87% |
| 2011 Q2 | 1.33 Billion DKK | 2.77% |
| 2011 Q1 | 1.29 Billion DKK | -9.67% |
| 2011 FY | 5.56 Billion DKK | 8.14% |
| 2011 Q4 | 1.57 Billion DKK | 15.75% |
| 2010 Q1 | 1.17 Billion DKK | -4.32% |
| 2010 FY | 5.14 Billion DKK | 8.8% |
| 2010 Q4 | 1.43 Billion DKK | 15.14% |
| 2010 Q3 | 1.24 Billion DKK | -2.95% |
| 2010 Q2 | 1.28 Billion DKK | 9.54% |
| 2009 Q3 | 1.1 Billion DKK | -7.36% |
| 2009 Q2 | 1.19 Billion DKK | -0.17% |
| 2009 FY | 4.72 Billion DKK | -15.91% |
| 2009 Q1 | 1.19 Billion DKK | 0.0% |
| 2009 Q4 | 1.22 Billion DKK | 10.74% |
| 2008 FY | 5.62 Billion DKK | -5.97% |
| 2007 FY | 5.98 Billion DKK | 75.24% |
| 2006 FY | 3.41 Billion DKK | -48.63% |
| 2005 FY | 6.64 Billion DKK | 19.75% |
| 2004 FY | 5.54 Billion DKK | 17.0% |
| 2003 FY | 4.74 Billion DKK | -13.97% |
| 2002 FY | 5.51 Billion DKK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Ambu A/S | 5.39 Billion DKK | -236.116% |
| ChemoMetec A/S | 407.87 Million DKK | -4342.592% |
| Demant A/S | 22.44 Billion DKK | 19.262% |
| Scandinavian Medical Solutions A/S | 191.19 Million DKK | -9377.405% |
| ViroGates A/S | 6.98 Million DKK | -259238.772% |